Mark Hurwitz, MD, FACRO, FASTRO

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6702
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Application of Forcing Functions to Electronic Health Records Is Associated With Improved Pain Control for Patients Undergoing Radiation Therapy for Bone Metastases
  2. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
  3. ACR-ACNM-ASTRO-SNMMI practice parameter for the performance of therapy with radium-223
  4. Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
  5. A phase IB clinical trial of 15 Gy HDR brachytherapy followed by hypofractionated/SBRT in the management of intermediate-risk prostate cancer
  6. Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer
  7. A Pilot Study of Radiation Therapy in Combination with Pembrolizumab in Patients with Metastatic Renal Cell Cancer
  8. Feasibility of removable balloon implant for simultaneous magnetic nanoparticle heating and HDR brachytherapy of brain tumor resection cavities
  9. Hyperthermia and immunotherapy: clinical opportunities
  10. Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy
  11. The docetaxel debate: Impact of chemotherapy in high-risk non-metastatic prostate cancer
  12. Quality assurance guidelines for interstitial hyperthermia
  13. Cancer of the urethra and penis
  14. Long-term outcomes of partial prostate treatment with magnetic resonance imaging-guided brachytherapy for patients with favorable-risk prostate cancer
  15. Dual Modality Implant for Simultaneous Magnetic Nanoparticle Heating and Brachytherapy Treatment of Tumor Resection Cavities in Brain
  16. Performance of a Prostate Cancer Genomic Classifier in Predicting Metastasis in Men with Prostate-specific Antigen Persistence Postprostatectomy
  17. Chemotherapy and radiation for prostate cancer
  18. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  19. Role of genetic testing for inherited prostate cancer risk: Philadelphia prostate cancer consensus conference 2017
  20. Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621
  21. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements
  22. Quality assurance guidelines for superficial hyperthermia clinical trials: II. Technical requirements for heating devices
  23. Oncologic applications of magnetic resonance guided focused ultrasound
  24. Using a conformal water bolus to adjust heating patterns of microwave waveguide applicators
  25. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies